Bausch & Lomb to buy eyeonics

Article

Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.

Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.

Upon completion of the deal, Bausch & Lomb will absorb eyeonics' operations as part of its surgical business. Eyeonics generated approximately $34 million in revenue in 2007, a 100% increase over the prior year.

The acquisition is expected to complete within the first quarter of 2008.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.